Senior insider sale
CMO at LONGBOARD PHARMACEUTICALS, INC. — senior position signals high conviction
$1.72M
50K shares
What this filing means
KAYE RANDALL plans to sell 50K shares of LONGBOARD PHARMACEUTICALS, INC. valued at approximately $1.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2024ACC: 0001950047-24-007112
Officer· CMO
Since Mar 2022
50K
Shares to sell
$1.72M
Approx. market value
33.33K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/16/2024
33.33KTotal acquired33.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2024 | Exercise of Stock Options Cash | 33.33K | — |
| Total | 33.33K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.67K
Market value
$578.8K
8/12/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
33.33K
Market value
$1.14M
9/16/2024
Total
Units
50K
Value
$1.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/12/2024 | 16.67K | $578.8K | — | Completed |
| Planned — Approximate Date | ||||
9/16/2024 | 33.33K | $1.14M | NASDAQ | Planned |
| Total | 50K | $1.72M | ||